Phase I Study Of Ytb323, A Chimeric Antigen Receptor (Car)-T Cell Therapy Manufactured Using T-Charge(tm), In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
YTB-323
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I Study Of Ytb323, A Chimeric Antigen Receptor (Car)-T Cell Therapy Manufactured Using T-Charge(tm), In Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma ### Output: YTB-323